Las Vegas Sun

March 29, 2024

Ruvo Center seeks participants for Alzheimer’s study

symphony park

Steve Marcus

The Cleveland Clinic Lou Ruvo Center for Brain Health is shown in the Symphony Park development in downtown Las Vegas on Feb. 2, 2012.

The Cleveland Clinic Lou Ruvo Center for Brain Health is looking for people with mild to moderate forms of Alzheimer's disease to participate in a six-month study.

The participants would be part of a multicenter Alzheimer's disease treatment trial called Rasagiline Rescue (R2). Researchers hope to determine if treatment with rasagiline — an FDA-approved drug to treat Parkinson's disease — results in both improved brain glucose metabolism and memory.

Participants must be 50 to 90 years old and have a study partner willing and able to comply with required procedures and at least eight years of education.

The Alzheimer's Drug Discovery Foundation raised more than $1.2 million for the R2 study.

Contact Yolande Mucharbach at 702-685-7070 or [email protected] for more information about the R2 trial and how to enroll.

Join the Discussion:

Check this out for a full explanation of our conversion to the LiveFyre commenting system and instructions on how to sign up for an account.

Full comments policy